SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on March 23, 2022. The filing serves to announce the company's financial results for the three months and the full year ended December 31, 2021. The registrant is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the periods ended December 31, 2021, have been issued.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for Q4 and Full Year 2021 in the attached Exhibit 99.1 press release.
- Confirm the company's cash position and burn rate as of December 31, 2021, to assess liquidity runway.
- Review the full text of the press release for any updated guidance or strategic shifts not detailed in this 8-K summary.
- Note that the financial data in this filing is "furnished" and not "filed," which may impact liability standards for the information provided.